Skip to main content
. 2021 Sep 7;36(11):2935–2947. doi: 10.1093/humrep/deab197

Table III.

Association between retinal microvasculature (in tertiles) and time to pregnancy after multiple imputation.

Retinal vascular features Time to pregnancy
Model 1
Model 2
Model 3
FOR (95% CI) FOR (95% CI) FOR (95% CI)
Retinal arteriolar features
 CRAE
  T1 0.96 (0.71, 1.28) 0.95 (0.70, 1.29) 0.93 (0.69, 1.27)
  T2 0.93 (0.70, 1.25) 0.92 (0.69, 1.24) 0.91 (0.68, 1.23)
  T3 Ref. Ref. Ref.
  P for trend 0.76 0.75 0.66
 DF-a
  T1 0.76 (0.57, 1.02) 0.76 (0.57, 1.02) 0.73 (0.55, 0.98)
  T2 0.70 (0.52, 0.94) 0.70 (0.52, 0.94) 0.68 (0.51, 0.92)
  T3 Ref. Ref. Ref.
  P for trend 0.06 0.07 0.04
 BA-a
  T1 0.84 (0.63, 1.13) 0.84 (0.63, 1.13) 0.81 (0.60, 1.08)
  T2 0.89 (0.66, 1.18) 0.88 (0.66, 1.18) 0.85 (0.63, 1.13)
  T3 Ref. Ref. Ref.
  P for trend 0.25 0.25 0.15
Retinal venular features
 CRVE
  T1 Ref. Ref. Ref.
  T2 1.05 (0.78, 1.41) 1.04 (0.77, 1.40) 1.02 (0.76, 1.38)
  T3 1.17 (0.87, 1.58) 1.18 (0.87, 1.58) 1.17 (0.87, 1.59)
  P for trend 0.29 0.29 0.30
 DF-v
  T1 0.84 (0.62, 1.13) 0.85 (0.63, 1.15) 0.83 (0.61, 1.12)
  T2 1.03 (0.78, 1.38) 1.04 (0.78, 1.38) 0.96 (0.72, 1.28)
  T3 Ref. Ref. Ref.
  P for trend 0.25 0.31 0.30
 BA-v
  T1 0.76 (0.56, 1.01) 0.76 (0.57, 1.01) 0.77 (0.57, 1.02)
  T2 Ref. Ref. Ref.
  T3 0.73 (0.54, 0.98) 0.73 (0.54, 0.98) 0.75 (0.56, 1.02)

FOR, fecundability odds ratio; T1, the lowest tertile; T2, the middle tertile; T3, the highest tertile; CRAE, central retinal arteriolar equivalent value; CRVE, central retinal venular equivalent value; DF-a, fractal dimension-arteriole; DF-v, fractal dimension-venule; BA-a, branching angle-arteriole; BA-v, branching angle-venule, value.

Model 1: Adjusted for maternal age, ethnicity (Chinese vs Malay vs Indian vs Others), college education (yes vs no) and EPDS score (≥14 vs <14) collected at study entry.

Model 2: Model 1 and maternal STAI score (≥75th vs <75th percentile), systolic blood pressure, physical activity (inactive vs minimally active vs HEPA active) and micronutrient dietary supplements intake (yes vs no) at study entry.

Model 3: Model 2 and additionally adjusted for BMI at study entry (underweight vs normal weight vs overweight vs obese) and fasting plasma glucose (≥5.1 vs <5.1 mmol/L) at study entry.